“Evaluation of Thiol Disulfide, Ischemia Modified Albumin, and Prolidase Parameters in Patients With Localized Scleroderma” (2024) Dermatology Practical & Conceptual, 14(4), p. e2024249. doi:10.5826/dpc.1404a249.